Vascular Effects of Dietary Salt in Humans With Salt-Resistant Blood Pressure

November 27, 2023 updated by: William Farquhar, University of Delaware

Vascular Effects of Dietary Salt in Humans With Salt-Resistant Blood Pressure: Dietary Counseling Study

The purpose of this study is to determine the effects of dietary salt restriction on central hemodynamics and vascular function in men and women with salt resistant blood pressure.

Study Overview

Status

Recruiting

Conditions

Detailed Description

Cardiovascular disease remains a major Public Health problem and is the leading cause of death in the US. Dietary sodium restriction is considered an important lifestyle modification for individuals with hypertension; however, there is controversy about the effects of dietary salt given that many individuals do not have "salt sensitive" blood pressure. Deleterious effects of salt on the vasculature may explain the finding that chronic DSR reduces the cardiovascular event rate by 25%despite only minor reductions in BP. It is not known whether dietary sodium restriction improves central pulsatile hemodynamics, known to be related to the development of left ventricular hypertrophy and heart failure risk, and whether the hypothesized improvements in central hemodynamics are similar in men & women. The purpose of this study is to determine the effects of dietary sodium restriction through dietary counseling on central hemodynamics and vascular function in men and women with salt resistant blood pressure.

Study Type

Interventional

Enrollment (Estimated)

125

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: William B Farquhar, PhD
  • Phone Number: 302-831-6178
  • Email: wbf@udel.edu

Study Contact Backup

  • Name: David G Edwards, PhD
  • Phone Number: 302-831-3363
  • Email: dge@udel.edu

Study Locations

    • Delaware
      • Newark, Delaware, United States, 19713
        • Recruiting
        • Department of Kinesiology and Applied Physiology, University of Delaware
        • Contact:
          • William B Farquhar, PhD
          • Phone Number: 302-831-6178
          • Email: wbf@udel.edu
        • Contact:
          • David G Edwards, PhD
          • Phone Number: 302-831-3363
          • Email: dge@udel.edu
        • Principal Investigator:
          • David G Edwards, PhD
        • Principal Investigator:
          • William B Farquhar, PhD
        • Principal Investigator:
          • Shannon Lennon, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Habitual dietary sodium intake > 3400mg per day

Exclusion Criteria:

  • Abnormal resting ECG
  • Current abnormal blood panel (assessed by comprehensive metabolic panel, lipid panel and complete blood count).
  • Hypertension (currently taking anti-hypertensive medications or resting blood pressure >140/90 mmHg)
  • Medical history of cardiovascular disease, malignant cancer, diabetes or kidney disease
  • Obesity (Body Mass Index > 30)
  • Current pregnancy
  • Unable to provide consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Dietary Sodium Restriction
Daily habitual dietary sodium intake < 2000mg
A registered dietician will counsel participants to reduce daily habitual dietary salt intake below 2000mg over 4 weeks
Sham Comparator: Control
Routine habitual dietary sodium intake >3400mg
Participants will consume their routine habitual dietary sodium intake > 3400mg per day with regular pre determined check in phone calls from a registered dietician.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reflected Pulse Wave Amplitude
Time Frame: Change from baseline at 4 weeks
Late systolic pulsatile load on the left ventricle represented by reflected pulse wave amplitude; assessed by echocardiography combined with applanation tonometry.
Change from baseline at 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Microvascular Function
Time Frame: Change from baseline at 4 weeks
Cutaneous microvascular dilatory response to local heating assessed by laser Doppler flowmetry coupled with intradermal microdialysis
Change from baseline at 4 weeks
Conduit Artery Endothelial Dependent Dilation
Time Frame: Change from baseline at 4 weeks
Brachial artery flow mediated dilation assessed by duplex ultrasound
Change from baseline at 4 weeks
Arterial Stiffness
Time Frame: Change from baseline at 4 weeks
Carotid - Femoral pulse wave velocity assessed by applanation tonometry
Change from baseline at 4 weeks
Forward pulse wave amplitude
Time Frame: Change from baseline at 4 weeks
Central hemodynamic assessment of the forward pulse wave amplitude assessed by echocardiography combined with applanation tonometry.
Change from baseline at 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: William B Farquhar, PhD, University of Delaware
  • Principal Investigator: David G Edwards, PhD, University of Delaware
  • Principal Investigator: Shannon Lennon, PhD, University of Delaware

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 21, 2018

Primary Completion (Estimated)

March 1, 2024

Study Completion (Estimated)

March 1, 2024

Study Registration Dates

First Submitted

January 29, 2018

First Submitted That Met QC Criteria

February 5, 2018

First Posted (Actual)

February 7, 2018

Study Record Updates

Last Update Posted (Actual)

November 28, 2023

Last Update Submitted That Met QC Criteria

November 27, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Dietary Sodium Restriction

3
Subscribe